Document is current
Any future updates will be listed below
-
Authors
Choe, James
Gaurav, Ahana
Xia, Eric
Yan, Allison
Mostaghimi, Arash
Barbieri, John S.
-
Funding
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (1K23AR078930)
- License Information
-
More Information
Article History
Received: 14 August 2024
Revised: 14 August 2024
Accepted: 20 August 2024
First Online: 3 September 2024
Declarations
:
: This study was approved by the Mass General Brigham (MGB) Institutional Review Board (2023P003245).
: Not applicable.
: John S. Barbieri.
: The National Institute of Arthritis and Musculoskeletal and Skin Diseases had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
: Dr. Barbieri reported personal fees from Dexcel Pharma for consulting outside the submitted work. Dr. Mostaghimi has received consulting fees from Pfizer, hims, Digital Diagnostics, Concert, Lilly, and AbbVie as well as licensing/royalties from Pfizer and Concert and holds equity in and is on the advisory board for hims and Fig. 1. No other disclosures were reported.
